Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hematopoietic Stem Cell Transplantation in High Risk Fanconi Anemia
NCT00258427Phase 2Completed
- Sponsor
- Masonic Cancer Center
- Start
- Mar 2002
- Primary completion
- Oct 2020
- Modality
- Monoclonal Antibodies, Stem Cell Therapies, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of Hematopoietic Stem Cell Transplantation (Medical College of Wisconsin) in Fanconi anemia (FA) (4 arms), sponsored by Masonic Cancer Center. Primary endpoint: Number of Participants Experiencing Graft Failure at 30 days. Started Mar 2002; status: completed.
02
Drugs
Hematopoietic Stem Cell Transplantation (Medical College of Wisconsin)
03
Conditions
Fanconi anemia (FA)
Beyond the preview
Go deeper on NCT00258427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00258427.